Advertisement

Topics

PAREXEL International Appoints Simon Harford as Senior Vice President and Chief Financial Officer

07:00 EST 28 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Appointment Effective June 1, 2017 PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment of Simon Harford as Senior Vice President and Chief F...

Other Sources for this Article

Media:
Erik Kopp
Tel.: +1 781-434-5304
Email: erik.kopp@PAREXEL.com
or
Jenny Radloff, PAN Communications
Tel: +1 617-502-4300
Email: PAREXEL@pancomm.com
or
Investors:
Ronald Aldridge
Tel.: +1-781-434-4753
Email: ron.aldridge@PAREXEL.com

NEXT ARTICLE

More From BioPortfolio on "PAREXEL International Appoints Simon Harford as Senior Vice President and Chief Financial Officer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...